Retail Clinics

CAMP HILL, Pa. One week after Walgreens announced that it was offering pertussis immunizations at its California locations, Rite Aid has followed suit.

Rite Aid said Monday that pharmacists at more than 500 Rite Aid stores across the state will offer pertussis, or whooping cough, vaccinations to individuals ages 7 years and older. The disease already has claimed the lives of nine infants in the state and is on pace to become the worst epidemic the state has seen in 50 years.

ST. PAUL, Minn. — A Target-funded study, conducted by the University of Minnesota Food Industry Center, found that hunger costs Minnesota residents more than $1.62 billion annually in direct and indirect health and education costs.

DENVER Weight-management products maker Atkins Nutritionals has introduced five new products for its Advantage, Day Break and Endulge lines.

NEW YORK Pfizer’s over-the-counter division recalled one lot of a ThermaCare product over the possibility of leaks.

 

Pfizer Consumer Healthcare announced Friday the voluntary recall of lot number E06931 of its ThermaCare HeatWraps Menstrual product and notified the Food and Drug Administration.

 

 

The company said possible leaks in the wraps could cause skin injury, such as irritation and burning.

 

SPANISH SPRINGS, Nev. Walmart and St. Mary's Medical Group will be opening on Oct. 18 a retail-based health clinic in Spanish Springs, Nev., according to a local news report.

The Clinic at Walmart will be located inside the Walmart at 5065 Pyramid Highway. This opening will mark the region's first retail clinic, according to the article.

It is the 90th such clinic for Walmart, which has in-store clinics in 21 states.

HUENENBERG, Switzerland Eyecare company Alcon has launched a new drug for inflammatory eye conditions.

 

Alcon announced the launch of TobraDex ST (tobramycin, dexamethasone ophthalmic suspension) in the 0.3%/0.5% strength. The drug is used to treat inflammatory eye conditions treatable with corticosteroids and where bacterial infection or risk of infection exists.

 

 

SILVER SPRING, Md. The Food and Drug Administration has moved to significantly restrict access to a controversial diabetes drug made by GlaxoSmithKline.

The agency said Thursday that it would restrict access to the Type 2 diabetes medication Avandia (rosiglitazone) in response to clinical study data suggesting that its use can increase the risk of heart attacks and strokes.

SAN RAMON, Calif. The Special Interest Group for IIAS Standards announced Wednesday that the group is making significant changes to its Eligible Products List — a list of over-the-counter products eligible for reimbursement under flexible spending accounts — in response to IRS guidance issued earlier this month.